Tag Archives: GLP-1 antagonist
Avexitide: a GLP-1 Blocker Cuts Hypoglycaemia by 55%
Avexitide blocks the GLP-1 receptor instead of activating it. Amylyx reports a 55% cut in hypoglycaemic events in a 78-participant phase 3 trial.
No account yet?
Create an AccountJoin the list for batch updates and new compound announcements. We will send you a single-use 8% code once you confirm your address.
Every batch is tested separately
Purity is measured per production lot, not once per product.
See the batch records